METHOD FOR CORRECTION OF SECONDARY MUCOCILIARY INSUFFICIENCY OF LOWER AIRWAY IN PATIENTS WITH BRONCHOPULMONARY DISEASES Russian patent published in 2015 - IPC A61N5/67 A61B5/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to pulmonology, and can be used for the correction of secondary mucociliary insufficiency (MCI) of the lower airway (LA) in the patients with bronchopulmonary diseases. A projection of bronchi and lungs in sub-clavian region, interscapular space and axillar region from both sides is exposed to a pulsed low-intensity infrared laser light at wave length of 0.89 mcm. A degree of mucociliary insufficiency is pre-determined. The exposure is characterised by an average-power emission of 3.75 mW at pulse repetition frequency 500 Hz. Degree 1 secondary mucociliary insufficiency of the lower airway requires 7 or 8 6-minute sessions. Degree 2 implies 7.5-minute sessions in number of 9 or 10. If observing degree 3, 11 or 12 daily sessions last for 9 minutes every day.

EFFECT: method enables increasing the clinical effectiveness in bronchopulmonary diseases by differentiating mode of the laser correction of MCI depending on a degree of manifestation that enables restoring the mucociliary transport.

5 tbl, 3 ex